Physician profile
Vanaja Kethireddy
NPI 1518083013
$950.59
in general payments reported to CMS, 2019-2025
20 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $38.66 · 2021: $179 · 2022: $195 · 2023: $119 · 2024: $121 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $224.79 | 2022-2025 | Aptima |
| Abbvie INC. | $135.80 | 2019-2022 | |
| Pfizer INC. | $89.75 | 2019-2023 | |
| Roche Diagnostics Corporation | $72.77 | 2019-2020 | |
| Avion Pharmaceuticals | $60.63 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $55.56 | 2021-2022 | |
| Millicent US INC | $34.99 | 2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $33.09 | 2022 | |
| Merck Sharp & Dohme LLC | $31.84 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $30.76 | 2022-2025 | |
| Shield Therapeutics INC | $30.58 | 2023 | Accrufer |
| Acessa Health INC. | $26.35 | 2019 | |
| Exeltis, USA INC. | $23.97 | 2022 | |
| Radius Health, INC. | $18.49 | 2019 | |
| Biogen, INC. | $17.38 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $17.32 | 2024 | Paragard T 380a |
| Daiichi Sankyo INC. | $16.30 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.63 | 2020 | |
| Minerva Surgical, INC | $12.30 | 2019 | |
| Meditrina | $4.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanaja Kethireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.